TABLE 2

Basic and clinical characteristics at recruitment between 1995 and 1999, comparing subjects in remission and subjects with persistent asthma at follow-up

AllPersistent asthmaRemissionp-value
Subjects n20518223
Female sex134 (65.4)121 (66.5)13 (56.5)0.344
Age at asthma onset39.3±10.339.4±10.238.6±11.60.718
BMI25.9±4.525.9±4.426.7±4.70.386
Family history of asthma83 (40.5)77 (42.3)6 (26.1)0.135
BMI classification
 Normal weight95 (46.3)85 (46.7)10 (43.5)
 Overweight79 (38.5)70 (38.5)9 (39.1)
 Obesity31 (15.1)27 (14.8)4 (17.4)0.717+
Smoking habits
 Nonsmoker105 (51.2)95 (52.2)10 (43.5)
 Ex-smoker64 (31.2)57 (31.3)7 (30.4)
 Current smoker36 (17.6)30 (16.5)6 (26.1)0.276+
 Occupational exposure to gas, dust or fumes66 (33.3)61 (34.9)5 (21.7)0.210
Educational level
 Primary school21 (10.5)20 (11.3)1 (4.3)
 High school92 (46.0)81 (45.8)11 (47.8)
 Higher education87 (43.5)76 (42.9)11 (47.8)0.417+
Lung function
 FEV1 % predicted89.0±13.488.3±13.794.6±10.10.034
 FVC % predicted87.1±11.686.5±11.792.0±9.50.034
Bronchial hyperreactivity PC20#
 PC20 ≤1 mg·mL−189 (48.1)83 (50.9)6 (27.3)0.037
 PC20 ≤2 mg·mL−1120 (64.9)109 (66.9)11 (50.0)0.120
Atopic comorbidities
 Hay fever82 (40.0)73 (40.1)9 (39.1)0.928
 Eczema68 (33.2)62 (34.1)6 (26.1)0.444
 Nasal polyps21 (10.2)20 (11.0)1 (4.3)0.285
 Positive skin-prick test85 (42.1)75 (41.9)10 (43.5)0.885

Data are presented as n (%) or mean±sd, unless otherwise stated. BMI: body mass index; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; PC20: provocative concentration causing a 20% fall in FEV1. #: among the 185 participating in metacholine challenge test at recruitment; : among the 202 participating in skin-prick test; +: analysis performed in a 3×2 table. Bold values indicate p<0.05.